PYC.AX
Price:
$1.28
Market Cap:
$597.26M
PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of drug solutions in the areas of ribonucleic acid therapeutics in Australia. The company's preclinical development programs include VP-001, drug program for retinitis pigmentosa type 11; and PYC-001, a drug program for the treatment of autosomal dominant optic atrophy. It also focuses on the development of programs for kidney, retinal, and central nervous system diseases. PYC Therapeutics Limited has academic-industry collaborations with Murdoch University to support drug discovery and development efforts in the field of neurodegenerative disorders, including Motor Neurone Disease. The company was...[Read more]
Industry
Biotechnology
IPO Date
2005-03-30
Stock Exchange
ASX
Ticker
PYC.AX
According to PYC Therapeutics Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 531.50M. This represents a change of -83.67% compared to the average of 3.26B of the last 4 quarters.
The mean historical Enterprise Value of PYC Therapeutics Limited over the last ten years is 1.98B. The current 531.50M Enterprise Value has changed 2.59% with respect to the historical average. Over the past ten years (40 quarters), PYC.AX's Enterprise Value was at its highest in in the June 2021 quarter at 4.97B. The Enterprise Value was at its lowest in in the March 2009 quarter at 0.
Average
1.98B
Median
1.49B
Minimum
244.52M
Maximum
4.83B
Discovering the peaks and valleys of PYC Therapeutics Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 382.86%
Maximum Annual Enterprise Value = 4.83B
Minimum Annual Increase = -57.28%
Minimum Annual Enterprise Value = 244.52M
Year | Enterprise Value | Change |
---|---|---|
2024 | 4.65B | 157.74% |
2023 | 1.80B | -12.60% |
2022 | 2.06B | -57.28% |
2021 | 4.83B | 51.69% |
2020 | 3.18B | 311.68% |
2019 | 773.66M | 36.19% |
2018 | 568.07M | -51.89% |
2017 | 1.18B | 382.86% |
2016 | 244.52M | -49.38% |
2015 | 483.09M | 77.04% |
The current Enterprise Value of PYC Therapeutics Limited (PYC.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.84B
5-year avg
3.31B
10-year avg
1.98B
PYC Therapeutics Limited’s Enterprise Value is greater than Pharmaxis Ltd (13.09M), less than Neuren Pharmaceuticals Limited (1.52B), greater than Patrys Limited (3.93M), greater than PharmAust Limited (102.21M), less than Antisense Therapeutics Limited (0),
Company | Enterprise Value | Market cap |
---|---|---|
13.09M | $20.23M | |
1.52B | $1.52B | |
3.93M | $6.17M | |
102.21M | $111.93M | |
0 | $52.29M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PYC Therapeutics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like PYC Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is PYC Therapeutics Limited's Enterprise Value?
What is the highest Enterprise Value for PYC Therapeutics Limited (PYC.AX)?
What is the 3-year average Enterprise Value for PYC Therapeutics Limited (PYC.AX)?
What is the 5-year average Enterprise Value for PYC Therapeutics Limited (PYC.AX)?
How does the current Enterprise Value for PYC Therapeutics Limited (PYC.AX) compare to its historical average?